Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Zacks News
Zacks Industry Outlook Highlights Korn Ferry, Cross Country Healthcare and Kelya
by Zacks Equity Research
Korn Ferry, Cross Country Healthcare and Kelya have been highlighted in this Industry Outlook article.
Heidrick & Struggles (HSII) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Heidrick & Struggles (HSII) delivered earnings and revenue surprises of 21.43% and 1.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Stocks to Watch in a Challenging Staffing Services Industry
by Sanjana Goswami
Gradual resumption of business activities, increased dependency on technology, the shift in recruitment patterns within the industry and cost reduction should aid the Zacks Staffing industry. KFY, CCRN and KELYA are well poised to witness a demand surge.
IQVIA (IQV) Beats on Q2 Earnings & Revenues, Alters '22 View
by Zacks Equity Research
IQVIA's (IQV) second-quarter 2022 earnings and revenues surge year over year.
Interpublic Group (IPG) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Interpublic Group's (IPG) second-quarter 2022 earnings and revenues plunge year-over-year.
Equifax (EFX) Beats on Q2 Earnings, Trims 2022 Guidance
by Zacks Equity Research
Equifax's (EFX) second-quarter 2022 earnings and revenues increase year over year.
Omnicom (OMC) Q2 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Omnicom's (OMC) second-quarter 2022 earnings increase while revenues decline year over year.
What's in the Offing for IQVIA Holdings (IQV) in Q2 Earnings?
by Zacks Equity Research
IQVIA Holdings' (IQV) second-quarter 2022 earnings and revenues are likely to have risen year over year.
Interpublic (IPG) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Interpublic's (IPG) second-quarter 2022 revenues are likely to rise year over year.
What's in the Offing for Robert Half (RHI) in Q2 Earnings?
by Zacks Equity Research
Robert Half's (RHI) second-quarter 2022 earnings and revenues are likely to have improved on a year-over-year basis.
Equifax (EFX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Equifax's (EFX) second-quarter 2022 earnings and revenues are likely to increase year over year.
What's in Store for ManpowerGroup (MAN) in Q2 Earnings?
by Zacks Equity Research
ManpowerGroup's (MAN) second-quarter 2022 earnings and revenues are likely to have increased year over year.
Omnicom (OMC) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Omnicom's (OMC) second-quarter 2022 earnings are likely to have increased year over year.
5 Broker-Favorite Stocks to Withstand the Current Market Mayhem
by Maharathi Basu
For significant returns, investors should keep broker-friendly stocks like C.H. Robinson (CHRW), Bunge Limited (BG), Cross Country Healthcare (CCRN), Bread Financial (BFH) and Commercial Metals Company (CMC) on their radar.
Cross Country Healthcare (CCRN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed the most recent trading day at $24.11, moving -1.11% from the previous trading session.
Cross Country (CCRN) Surges 8.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Cross Country (CCRN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
The Zacks Analyst Blog Highlights ZipRecruiter, Cross Country Healthcare, GEE Group and Resources Connection
by Zacks Equity Research
ZipRecruiter, Cross Country Healthcare, GEE Group and Resources Connection are part of Zacks top Analyst Blog
Cross Country Healthcare (CCRN) Just Overtook the 200-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
4 Staffing Stocks to Watch on Robust Job Additions to Economy
by Ritujay Ghosh
The United States has been adding a record number of jobs, helping staffing firm stocks ZipRecruiter, Inc. (ZIP), Cross Country Healthcare, Inc. (CCRN), GEE Group, Inc. (JOB) and Resources Connection, Inc. (RGP).
Will Cross Country (CCRN) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Cross Country (CCRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Stock Picks for Week of July 4, 2022
by Panel Of Zacks Experts
A Synopsis of Synopsys and a Healthcare Leader with a Diverse Client Base.
Here's Why You Should Retain Envestnet (ENV) Stock for Now
by Zacks Equity Research
Strong recurring revenue generation capacity and technology development boost Envestnet (ENV). However, lower liquidity is a concern.
Here's Why You Should Retain Insperity (NSP) Stock for Now
by Zacks Equity Research
Shareholder-friendly steps boost Insperity (NSP). However, lower liquidity is worrisome.
Accenture (ACN) Acquires Capabilities From Japan's Trancom ITS
by Zacks Equity Research
The acquisition is expected to strengthen Accenture's (ACN) digital engineering, manufacturing and logistics capabilities.
6 Reasons to Add Paychex (PAYX) Stock to Your Portfolio Now
by Zacks Equity Research
Paychex's (PAYX) efforts to capitalize on the rising opportunities in the professional employer organization industry look impressive. Acquisitions help boost revenue growth.